These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20076794)

  • 1. Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture.
    Sullivan JS; Selleck PW; Downton T; Boehm I; Axell AM; Ayob Y; Kapitza NM; Dyer W; Fitzgerald A; Walsh B; Lynch GW
    J Mol Genet Med; 2009 Dec; 3(2):217-24. PubMed ID: 20076794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.
    Lynch GW; Selleck P; Church WB; Sullivan JS
    Immunol Cell Biol; 2012 Feb; 90(2):149-58. PubMed ID: 21647170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza.
    Lynch GW; Selleck P; Sullivan JS
    J Mol Genet Med; 2009 Dec; 3(2):205-9. PubMed ID: 20076792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.
    Bodewes R; Kreijtz JH; Hillaire ML; Geelhoed-Mieras MM; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Gen Virol; 2010 Jul; 91(Pt 7):1743-53. PubMed ID: 20335492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.
    Kreijtz JH; Bodewes R; van den Brand JM; de Mutsert G; Baas C; van Amerongen G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Vaccine; 2009 Aug; 27(36):4983-9. PubMed ID: 19538996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.
    Bodewes R; Kreijtz JH; Baas C; Geelhoed-Mieras MM; de Mutsert G; van Amerongen G; van den Brand JM; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    PLoS One; 2009; 4(5):e5538. PubMed ID: 19440239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
    Throsby M; van den Brink E; Jongeneelen M; Poon LL; Alard P; Cornelissen L; Bakker A; Cox F; van Deventer E; Guan Y; Cinatl J; ter Meulen J; Lasters I; Carsetti R; Peiris M; de Kruif J; Goudsmit J
    PLoS One; 2008; 3(12):e3942. PubMed ID: 19079604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
    Kamlangdee A; Kingstad-Bakke B; Osorio JE
    J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza.
    Goy K; Von Bibra S; Lewis J; Laurie K; Barr I; Anderson D; Hellard M; Ffrench R
    Influenza Other Respir Viruses; 2008 Jul; 2(4):115-25. PubMed ID: 19453462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of heterosubtypic cross-protection against highly pathogenic H5N1 by active infection with human seasonal influenza A virus or trivalent inactivated vaccine immunization in ferret models.
    Park SJ; Kim EH; Pascua PNQ; Kwon HI; Lim GJ; Decano A; Kim SM; Song MK; Shin EC; Choi YK
    J Gen Virol; 2014 Apr; 95(Pt 4):793-798. PubMed ID: 24421115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
    Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
    Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge.
    Nachbagauer R; Shore D; Yang H; Johnson SK; Gabbard JD; Tompkins SM; Wrammert J; Wilson PC; Stevens J; Ahmed R; Krammer F; Ellebedy AH
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.
    Corti D; Suguitan AL; Pinna D; Silacci C; Fernandez-Rodriguez BM; Vanzetta F; Santos C; Luke CJ; Torres-Velez FJ; Temperton NJ; Weiss RA; Sallusto F; Subbarao K; Lanzavecchia A
    J Clin Invest; 2010 May; 120(5):1663-73. PubMed ID: 20389023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-exposing Canada Geese (Branta canadensis) to a low-pathogenic H1N1 avian influenza virus protects them against H5N1 HPAI virus challenge.
    Berhane Y; Embury-Hyatt C; Leith M; Kehler H; Suderman M; Pasick J
    J Wildl Dis; 2014 Jan; 50(1):84-97. PubMed ID: 24171557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.
    Straight TM; Ottolini MG; Prince GA; Eichelberger MC
    Virol J; 2008 Mar; 5():44. PubMed ID: 18355405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.